Meguro, Japan

Hidetoshi Ogino

This inventor holds 1 USPTO granted patent. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hidetoshi Ogino: Innovator in Antiviral Pharmaceutical Composition

Introduction

Hidetoshi Ogino is a notable inventor based in Meguro, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. His innovative work has led to the creation of a unique guanidinobenzene derivative that holds promise for medical applications.

Latest Patents

Hidetoshi Ogino holds 1 patent for his invention titled "Guanidinobenzene derivatives." This patent describes a guanidinobenzene derivative represented by a specific formula, wherein R¹ represents a substituent selected from a phenyl group substituted by an amidino group and a naphthyl group substituted by an amidino group. The patent also details a process for the production of this compound and an antiviral pharmaceutical composition that includes it.

Career Highlights

Ogino is associated with Banyu Pharmaceutical Co. Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the understanding and potential treatment of viral infections through innovative chemical compounds.

Collaborations

Hidetoshi Ogino has collaborated with notable colleagues, including Akira Okuyama and Kyozo Naito. These partnerships have fostered a collaborative environment that enhances the research and development process within the pharmaceutical industry.

Conclusion

Hidetoshi Ogino's contributions to antiviral pharmaceutical compositions exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements in the field, showcasing the importance of research and collaboration in developing effective treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…